These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of intracameral cefuroxime on fibrinous uveitis after pediatric cataract surgery. Gradin D; Mundia D J Pediatr Ophthalmol Strabismus; 2011; 48(1):45-9. PubMed ID: 20438039 [TBL] [Abstract][Full Text] [Related]
8. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery. Osaadon P; Belfair N; Lavy I; Walter E; Levy J; Tuuminen R; Achiron A; Knyazer B Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630 [TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery. Schmitz K; Greite JH; Bartenschlager EM Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512 [TBL] [Abstract][Full Text] [Related]
10. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification. Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778 [TBL] [Abstract][Full Text] [Related]
11. Dissolution of pseudophakic fibrinous exudate with intraocular streptokinase. Mullaney PB; Wheeler DT; al-Nahdi T Eye (Lond); 1996; 10 ( Pt 3)():362-6. PubMed ID: 8796163 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation]. Xie L; Li S; Dong X; Cao J; Shi W; Guo P Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):291-3. PubMed ID: 11877211 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery. Ozveren F; Eltutar K J Cataract Refract Surg; 2004 Aug; 30(8):1727-31. PubMed ID: 15313298 [TBL] [Abstract][Full Text] [Related]
15. Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis. Wu TT; Wang HH Eye (Lond); 2009 Jan; 23(1):101-7. PubMed ID: 17901882 [TBL] [Abstract][Full Text] [Related]
16. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis]. Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762 [TBL] [Abstract][Full Text] [Related]
17. Recombinant tissue plasminogen activator (r-TPA) in fibrin dissolution due to postoperative endophthalmitis. Riaz Y; Mehta JS; Fernando A; Ferguson V Ann Acad Med Singap; 2006 Oct; 35(10):723-5. PubMed ID: 17102897 [TBL] [Abstract][Full Text] [Related]
18. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery. Wedrich A; Menapace R; Mühlbauer-Ries E Int Ophthalmol; 1994-1995; 18(5):277-80. PubMed ID: 7607808 [TBL] [Abstract][Full Text] [Related]
19. Pediatric cataract surgery in Nepal. Thakur J; Reddy H; Wilson ME; Paudyal G; Gurung R; Thapa S; Tabin G; Ruit S J Cataract Refract Surg; 2004 Aug; 30(8):1629-35. PubMed ID: 15313283 [TBL] [Abstract][Full Text] [Related]
20. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery. Wedrich A; Menapace R; Ries E; Polzer I J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]